XML 113 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Pay Versus Performance Disclosure
In accordance with rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we provide the following disclosure regarding executive compensation for our principal executive officer (“PEO”) and
Non-PEO
NEOs and Company performance for the fiscal years listed below. The HR and Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown.
 
Year
  
Summary
Compensation
Table Total for
PEO 1
($)
(1)
    
Summary
Compensation
Table Total
for PEO 2
($)
(1)
    
Compensation
Actually Paid
to PEO 1
($)
(1)(2)(3)
    
Compensation
Actually Paid
to PEO 2
($)
(1)(2)(3)
    
Average
Summary
Compensation
Table Total
for
Non-PEO

NEOs
($)
(1)
    
Average
Compensation
Actually Paid
to
Non-PEO

NEOs
($)
(1)(2)(3)
     
Value of Initial
Fixed $100
Investment based
on:
(4)
     
Net
Income
($ Millions)
    
Net
Revenue
($ Millions)
(5)
  
  
TSR
($)
    
Peer
Group
TSR
($)
  
(a)
  
(b)
    
(b)
    
(c)
    
(c)
    
(d)
    
(e)
     
(f)
    
(g)
     
(h)
    
(i)
  
2024
  
 
 
 
 
 
 
  
 
15,518,947
 
  
 
 
 
 
 
 
  
 
40,920,263
 
  
 
5,645,290
 
  
 
12,940,595
 
   
 
224.90
 
  
 
135.41
 
   
 
(1,959)
 
  
 
16,544
 
2023
  
 
 
 
 
 
 
  
 
25,706,880
 
  
 
 
 
 
 
 
  
 
26,191,537
 
  
 
4,522,802
 
  
 
4,825,132
 
   
 
106.53
 
  
 
124.97
 
   
 
(615)
 
  
 
15,846
 
2022
  
 
15,529,138
 
  
 
 
 
 
 
 
  
 
17,214,057
 
  
 
 
 
 
 
 
  
 
3,977,166
 
  
 
4,426,020
 
   
 
93.06
 
  
 
123.43
 
   
 
(2,499)
 
  
 
14,925
 
2021
  
 
14,681,772
 
  
 
 
 
 
 
 
  
 
7,570,056
 
  
 
 
 
 
 
 
  
 
3,740,840
 
  
 
3,075,466
 
   
 
81.73
 
  
 
129.31
 
   
 
456
 
  
 
15,878
 
2020
  
 
15,724,518
 
  
 
 
 
 
 
 
  
 
10,866,321
 
  
 
 
 
 
 
 
  
 
3,997,258
 
  
 
3,783,167
 
   
 
98.47
 
  
 
114.32
 
   
 
(4,099)
 
  
 
16,659
 
(1)
Kåre Schultz (PEO 1) was our PEO for the years 2020 through 2022. Richard Francis (PEO 2) was the CEO in 2023 and 2024. The individuals comprising the
Non-PEO
NEOs for each year presented are listed below.
 
2020
  
2021
  
2022
  
2023
  
2024
Eli Kalif
  
Eli Kalif
  
Eli Kalif
  
Eli Kalif
  
Eli Kalif
Dr. Hafrun Fridriksdottir
  
Dr. Sven Dethlefs
  
Dr. Sven Dethlefs
  
Richard Daniell
  
Dr. Eric Hughes
Brendan O’Grady
  
Eric Drapé
  
Mark Sabag
  
Eric Drapé
  
Richard Daniell
Eric Drapé
  
Mark Sabag
  
Eric Drapé
  
Mark Sabag
  
Christine Fox
 
(2)
The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation
S-K
and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
(3)
Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the
Non-PEO
NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards column are the totals from the Stock Awards columns set forth in the Summary Compensation Table.
 
Year
   
Summary Compensation
Table Total for PEO 2
($)
       
Exclusion of Stock
Awards and Option
Awards for PEO 2
($)
       
Inclusion of Equity
Values for PEO 2
($)
       
Compensation Actually
Paid to PEO 2
($)
  
2024
   
 
15,518,947
 
     
 
(8,999,988)
 
     
 
34,401,304
 
     
 
40,920,263
 
 
Year
   
Average Summary
Compensation Table
Total for Non-PEO NEOs

($)
       
Average Exclusion of
Stock Awards and
Option Awards for
Non-PEO
NEOs
($)
       
Average Inclusion of
Equity Values for
Non-PEO
NEOs
($)
       
Average Compensation
Actually Paid to
Non-PEO
NEOs
($)
  
2024
   
 
5,645,290
 
     
 
(3,524,983)
 
     
 
10,820,288
 
     
 
12,940,595
 
 
 
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
 
Year
   
Year-End
Fair
Value of
Equity Awards
Granted
During Year
That Remained
Unvested as of
Last Day of
Year for
PEO 2
($)
     
Change in Fair
Value from
Last Day of
Prior Year to
Last Day of
Year of
Unvested
Equity Awards
for
PEO 2
($)
     
Vesting-Date
Fair Value of
Equity Awards
Granted
During Year
that Vested
During Year
for
PEO 2
($)
     
Change in Fair
Value from
Last Day of
Prior Year to
Vesting Date
of Unvested
Equity Awards
that Vested
During Year
for
PEO 2
($)
     
Fair Value at
Last Day of
Prior Year of
Equity Awards
Forfeited
During Year
for
PEO 2
($)
     
Value of
Dividends or
Other
Earnings Paid
on Equity
Awards Not
Otherwise
Included for
PEO 2
($)
     
Total -
Inclusion of
Equity
Values for
PEO 2
($)
  
2024
   
 
14,758,910
 
   
 
18,994,534
 
   
 
0
 
   
 
647,860
 
   
 
0
 
   
 
0
 
   
 
34,401,304
 
 
Year
   
Average Year-

End Fair Value
of Equity
Awards
Granted
During Year
That Remained
Unvested as of
Last Day of
Year for
Non-PEO

NEOs
($)
     
Average
Change in Fair
Value from
Last Day of
Prior Year to
Last Day of
Year of
Unvested
Equity
Awards for
Non-PEO

NEOs
($)
     
Average
Vesting-Date
Fair Value of
Equity Awards
Granted
During Year
that Vested
During Year
for
Non-PEO

NEOs
($)
     
Average
Change in Fair
Value from
Last Day of
Prior Year to
Vesting Date
of Unvested
Equity Awards
that Vested
During Year
for
Non-PEO

NEOs
($)
     
Average Fair
Value at Last
Day of Prior
Year of Equity
Awards
Forfeited
During Year
for
Non-PEO

NEOs
($)
     
Average Value
of Dividends
or Other
Earnings Paid
on Equity
Awards Not
Otherwise
Included for
Non-PEO

NEOs
($)
     
Total - Average

Inclusion of
Equity Values
for
Non-PEO

NEOs
($)
  
2024
   
 
5,780,552
 
   
 
4,549,484
 
   
 
0
 
   
 
490,252
 
   
 
0
 
   
 
0
 
   
 
10,820,288
 
(4)
The Peer Group TSR set forth in this table utilizes the Dow Jones U.S. Select Pharmaceuticals Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation
S-K
included in our Annual Report for the year ended December 31, 2024. The comparison assumes $100 was invested for the period starting December 31, 2019, through the end of the listed year in the Company and in the Dow Jones U.S. Select Pharmaceuticals Total Return Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
(5)
We determined
Net Revenue
to be the most important financial performance measure used to link Company performance to Compensation Actually Paid to our PEO and
Non-PEO
NEOs in 2024. This performance measure may not have been the most important financial performance measure for years 2020 through 2023 and we may determine a different financial performance measure to be the most important financial performance measure in future years.
       
Company Selected Measure Name Net Revenue        
Named Executive Officers, Footnote
2020
  
2021
  
2022
  
2023
  
2024
Eli Kalif
  
Eli Kalif
  
Eli Kalif
  
Eli Kalif
  
Eli Kalif
Dr. Hafrun Fridriksdottir
  
Dr. Sven Dethlefs
  
Dr. Sven Dethlefs
  
Richard Daniell
  
Dr. Eric Hughes
Brendan O’Grady
  
Eric Drapé
  
Mark Sabag
  
Eric Drapé
  
Richard Daniell
Eric Drapé
  
Mark Sabag
  
Eric Drapé
  
Mark Sabag
  
Christine Fox
       
Peer Group Issuers, Footnote The Peer Group TSR set forth in this table utilizes the Dow Jones U.S. Select Pharmaceuticals Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation
S-K
included in our Annual Report for the year ended December 31, 2024. The comparison assumes $100 was invested for the period starting December 31, 2019, through the end of the listed year in the Company and in the Dow Jones U.S. Select Pharmaceuticals Total Return Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. 		       
Adjustment To PEO Compensation, Footnote
Year
   
Summary Compensation
Table Total for PEO 2
($)
       
Exclusion of Stock
Awards and Option
Awards for PEO 2
($)
       
Inclusion of Equity
Values for PEO 2
($)
       
Compensation Actually
Paid to PEO 2
($)
  
2024
   
 
15,518,947
 
     
 
(8,999,988)
 
     
 
34,401,304
 
     
 
40,920,263
 
       
Non-PEO NEO Average Total Compensation Amount $ 5,645,290 $ 4,522,802 $ 3,977,166 $ 3,740,840 $ 3,997,258
Non-PEO NEO Average Compensation Actually Paid Amount $ 12,940,595 4,825,132 4,426,020 3,075,466 3,783,167
Adjustment to Non-PEO NEO Compensation Footnote
Year
   
Average Summary
Compensation Table
Total for Non-PEO NEOs

($)
       
Average Exclusion of
Stock Awards and
Option Awards for
Non-PEO
NEOs
($)
       
Average Inclusion of
Equity Values for
Non-PEO
NEOs
($)
       
Average Compensation
Actually Paid to
Non-PEO
NEOs
($)
  
2024
   
 
5,645,290
 
     
 
(3,524,983)
 
     
 
10,820,288
 
     
 
12,940,595
 
       
Compensation Actually Paid vs. Total Shareholder Return
Relationship Between PEO and
Non-PEO
NEO Compensation Actually Paid, Total Shareholder Return (“TSR”) and Peer Group TSR
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our
Non-PEO
NEOs, and the cumulative TSR over the five most recently completed fiscal years for the Company and the Dow Jones U.S. Select Pharmaceuticals Total Return Index.
 
 
LOGO
       
Compensation Actually Paid vs. Net Income
Relationship Between PEO and
Non-PEO
NEO Compensation Actually Paid and Net Income
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our
Non-PEO
NEOs, and our Net Income during the five most recently completed fiscal years.
 
 
LOGO
       
Compensation Actually Paid vs. Company Selected Measure
Relationship Between PEO and
Non-PEO
NEO Compensation Actually Paid and Net Revenue
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our
Non-PEO
NEOs, and our Net Revenue during the five most recently completed fiscal years.
 
 
LOGO
       
Total Shareholder Return Vs Peer Group
Relationship Between PEO and
Non-PEO
NEO Compensation Actually Paid, Total Shareholder Return (“TSR”) and Peer Group TSR
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our
Non-PEO
NEOs, and the cumulative TSR over the five most recently completed fiscal years for the Company and the Dow Jones U.S. Select Pharmaceuticals Total Return Index.
 
 
LOGO
       
Tabular List, Table
Tabular List of Most Important Financial and
Non-Financial
Performance Measures
The following table presents the financial and
non-financial
performance measures that the Company considers to have been the most important in linking Compensation Actually Paid to our PEO and other NEOs for 2024 to Company performance. The measures in this table are not
ranked
.
 
Net Revenue
Free Cash Flow
Non-GAAP
Earnings Per Share
Stock Price
       
Total Shareholder Return Amount $ 224.9 106.53 93.06 81.73 98.47
Peer Group Total Shareholder Return Amount 135.41 124.97 123.43 129.31 114.32
Net Income (Loss) $ (1,959,000,000) $ (615,000,000) $ (2,499,000,000) $ 456,000,000 $ (4,099,000,000)
Company Selected Measure Amount 16,544,000,000 15,846,000,000 14,925,000,000 15,878,000,000 16,659,000,000
Measure:: 1          
Pay vs Performance Disclosure          
Name Net Revenue        
Measure:: 2          
Pay vs Performance Disclosure          
Name Free Cash Flow        
Measure:: 3          
Pay vs Performance Disclosure          
Name Non-GAAP Earnings Per Share        
Measure:: 4          
Pay vs Performance Disclosure          
Name Stock Price        
Kare Schultz [Member]          
Pay vs Performance Disclosure          
PEO Total Compensation Amount     $ 15,529,138 $ 14,681,772 $ 15,724,518
PEO Actually Paid Compensation Amount     $ 17,214,057 $ 7,570,056 $ 10,866,321
PEO Name     Kåre Schultz Kåre Schultz Kåre Schultz
Richard Francis [Member]          
Pay vs Performance Disclosure          
PEO Total Compensation Amount $ 15,518,947 $ 25,706,880      
PEO Actually Paid Compensation Amount $ 40,920,263 $ 26,191,537      
PEO Name Richard Francis Richard Francis      
PEO | Richard Francis [Member] | Equity Awards Adjustments          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 34,401,304        
PEO | Richard Francis [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 14,758,910        
PEO | Richard Francis [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 18,994,534        
PEO | Richard Francis [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
PEO | Richard Francis [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 647,860        
PEO | Richard Francis [Member] | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
PEO | Richard Francis [Member] | Stock Awards and Option Awards [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (8,999,988)        
PEO | Richard Francis [Member] | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Equity Awards Adjustments          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 10,820,288        
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 5,780,552        
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 4,549,484        
Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 490,252        
Non-PEO NEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Stock Awards and Option Awards [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (3,524,983)        
Non-PEO NEO | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 0